Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis
about
Comparative in vitro study on magnetic iron oxide nanoparticles for MRI tracking of adipose tissue-derived progenitor cellsMagnetic Resonance Imaging of Changes in Abdominal Compartments in Obese Diabetics during a Low-Calorie Weight-Loss ProgramNonalcoholic Fatty Liver Disease: Correlation of the Liver Parenchyma Fatty Acid with Intravoxel Incoherent Motion MR Imaging-An Experimental Study in a Rat Model.Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: Magnetic Resonance Imaging Is an Effective, Non-invasive Method to Evaluate Changes in the Liver Fat Fraction.Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI.Quantification of liver fat in the presence of iron overload.Cohort profile: Greifswald approach to individualized medicine (GANI_MED)Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis.Quantification of liver fat with respiratory-gated quantitative chemical shift encoded MRI.Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adultsAccuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as referenceMRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitis.Optimization of region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification.MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes.Quantification of renal steatosis in type II diabetes mellitus using dixon-based MRI.Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosis.Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis.Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging.Hypodense liver lesions in patients with hepatic steatosis: do we profit from dual-energy computed tomography?Assessment of liver fat content using quantitative ultrasonography to evaluate risks for metabolic diseases.Fat Quantification in the Abdomen.Non-invasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials.Abdominal fat deposits determined by magnetic resonance imaging in relation to leptin and vaspin levels as well as insulin resistance in the general adult population.High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance.[Techniques for quantification of liver fat in risk stratification of diabetics].Circulating osteopontin and its association with liver fat content in non-obese women with polycystic ovary syndrome: a case control study.Current status of imaging in nonalcoholic fatty liver disease
P2860
Q28543135-534A3AB4-16ED-452A-8C56-5E45B50B16DFQ28551574-3E3E1E1D-F3B8-40F5-A5BB-42FD893D7179Q31004631-DADAABAD-35CF-4A24-9E5C-413677B3618AQ31153508-D01A261A-85E2-4F64-8C5E-AC4EA78E675FQ31155800-88769A0A-7313-4F0E-A831-4F132A5A5874Q33645229-8233F05B-3247-43A4-9A7F-5A9117FA9D76Q33694054-E14FE1E7-CFCA-47C1-891C-A96894C75605Q35096971-E3674164-24ED-410D-B37E-054FD854374BQ36113235-D9F238A7-65C1-4243-AF81-186EDEEA3A3CQ36298345-70A61F48-D515-4833-B018-D4EDB2170951Q36762955-2126D790-E023-472A-96B3-B4854D655926Q36762975-0D283940-2AA1-4DF8-8346-1FA945D77508Q38603528-1A659F33-2026-4104-B4BA-F44AA25B7664Q38607460-BDBCBB08-8813-4B78-B896-8E658794A939Q38625205-F5CAE588-38B7-47AF-91F4-F3739CC5C920Q38786005-339CD955-04B1-484D-8F0B-E1057DEB05C5Q39329705-25AAD2AB-B9D8-436D-81D0-427DAEC636AEQ40047726-F3186B07-17A7-4E1A-81CF-ED251BB58113Q40211159-77CC55B2-EAED-43AF-81E2-01F073BAEA6CQ40932533-A94E066C-5143-4650-B57F-3F892A3616E8Q41517362-0A7CF278-AF18-4BB3-9F7E-A192CEA7B5B4Q45992724-7B1CC243-69EF-4745-8502-2F6D55D54AC7Q49884186-3742A382-DB3D-46D1-BCF5-2645F4F6E6C4Q50026043-392869BA-1EF1-4E5D-A048-F17A17B5F475Q51011840-01BFF08B-06B2-48DF-9056-5BFB0BED38A9Q53572525-A959AC5E-E451-4E18-8A1A-31C63FEDA441Q55263032-8B13B9B1-3D8D-4923-BF28-F91491888A10Q58700636-FEFCB318-4FF8-4B0F-821D-D6E0C1AF27C7
P2860
Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Quantitative chemical shift-en ...... to quantify hepatic steatosis
@ast
Quantitative chemical shift-en ...... to quantify hepatic steatosis
@en
Quantitative chemical shift-en ...... to quantify hepatic steatosis
@nl
type
label
Quantitative chemical shift-en ...... to quantify hepatic steatosis
@ast
Quantitative chemical shift-en ...... to quantify hepatic steatosis
@en
Quantitative chemical shift-en ...... to quantify hepatic steatosis
@nl
prefLabel
Quantitative chemical shift-en ...... to quantify hepatic steatosis
@ast
Quantitative chemical shift-en ...... to quantify hepatic steatosis
@en
Quantitative chemical shift-en ...... to quantify hepatic steatosis
@nl
P2093
P2860
P356
P1476
Quantitative chemical shift-en ...... to quantify hepatic steatosis
@en
P2093
Birger Mensel
Diego Hernando
Jens-Peter Kühn
Norbert Hosten
Paul C Krüger
Till Ittermann
P2860
P304
P356
10.1002/JMRI.24289
P577
2013-10-10T00:00:00Z